LIGUEROS-SAYLAN, MONICA,MATCHABA, PATRICE,THUREN, TOM,RIDKER, PAUL,LIBBY, PETER,OTTEWELL, PENELOPE,LAU, YANG YI,DUGAN, MARGARET
申请号:
CA3066045
公开号:
CA3066045A1
申请日:
2018.06.22
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
Use of an IL-1.beta. binding antibody or a functional fragment thereof,especially canakinumab or a functional fragmentthereof, or gevokizumab or a functional fragment thereof, and biomarkers forthe treatment and/or prevention of cancer with at leastpartial inflammatory basis.